Clarivate Plc (CLVT)
| Previous close | 6.76 |
| Open | 6.75 |
| Bid | 6.75 x 3000 |
| Ask | 6.76 x 1300 |
| Day's range | 6.74 - 6.84 |
| 52-week range | 6.07 - 10.03 |
| Volume | |
| Avg. volume | 4,191,434 |
| Market cap | 4.52B |
| Beta (5Y monthly) | 1.24 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
BioWorld by Clarivate Explores the Future of CAR T Therapy in Mainland China in Special Report
BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, explores the growing investment in CAR T therapy development in mainland China in a new series titled "China's CAR T market comes of age." The report examines the dynamic realm of CAR T-cell therapies in China, including the rapid pipeline growth, deals, clinical trials and challenging issues surrounding patient access to very expensive and effective cancer therapeutics.
- PR Newswire
Clarivate joins United Nations SDG Publishers Compact
Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announces it has signed the United Nations Sustainable Development Goals (UN SDGs) Publishers Compact. Signatories of the compact pledge to develop sustainable practices and act as champions of the SDGs during the Decade of Action (2020-2030).
- PR Newswire
Clarivate Acquires Global QMS, Inc., Expanding Life Sciences & Healthcare Segment into New Markets
Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced that it has acquired Global QMS, Inc., known as Global Q, a provider of cloud-based solutions that enable life sciences clients to automate regulatory reporting and compliance management. Financial terms of the transaction were not disclosed.
